1UO Pediatria I, 2UO Laboratorio di Genetica Medica, Azienda Ospedaliero-Universitaria Pisana, Ospedale “S. Chiara”, Pisa;
3UOC Pediatria, Azienda USL5, Pisa;
4UO Pediatria e Neonatologia, Presidio Ospedaliero, Fidenza;
5Dipartimento di Scienze Pediatriche Medico Chirurgiche e Neuroscienze dello Sviluppo, Policlinico Universitario “A. Gemelli”, Roma
Indirizzo per corrispondenza: firstname.lastname@example.org
Key words: Genetic mutation, Terminology of rickets, Vitamin D, Vitamin D-resistant rickets
The term “vitamin D-resistant rickets” was used to describe a clinical condition which was indistinguishable from the common rickets except that the signs occurred in spite of adequate vitamin D treatment. Recent studies showed that vitamin D-resistant rickets is due to genetic mutations of some enzymes involved in vitamin D activation, metabolism or action. This may explain why vitamin D treatment is not able to cure patients affected by these forms of rickets. Indeed, vitamin D metabolites (calcitriol, alfacalcidol) associated with calcium or phosphate salts according to the pathogenesis of the disease are the most effective treatments for patients affected by rickets due to genetic mutations. The evidence of a genetic mutation in a patient with rickets is crucial not only for a correct diagnosis and treatment, but also for prognosis.
Vuoi citare questo contributo?